Dr. Tan Miao was invited to give a lecture on “alumni lecture hall, wonderful life” at Nanjing University


Dr. Tan Miao was invited to give a lecture on “alumni lecture hall, wonderful life” at Nanjing University

Dr. Tan Miao, co-founder, chairman and general manager of HymonBio Co., Ltd.  at the invitation of the school of life sciences of Nanjing University, gave a lecture on "alumni lecture, wonderful life" in room a430 of the Academy of Biological Sciences at 14:00 on October 19 (Tuesday). The lecture content was "scientific and technological innovation promotes major epidemic prevention and control". Welcome master Nan and insiders to attend the lecture.


The founding team of HymonBio has served as the project leader of the sub project of detection products of major national special projects on infectious diseases. They have experienced many outbreaks in their career. After the outbreak of new infectious diseases, it is an urgent task to provide detection products for the front-line fight against the epidemic, including H1N1, h7n9, etc.

After the outbreak of COVID-19, Dr. Tan Miao led the Hai Miao biological team to complete the development and listing of the new crown nucleic acid detection kit (Hymon® SARS-CoV-2 Test Kit) within a week based on the proprietary MoLock nano antibody molecular locking technology and the OT buffer system technology. The realization of COVID-19 nucleic acid detection from the sample to the whole process needs only a single tube for 40 minutes to achieve the world leading level. It has been approved by FDA EUA of the United States and CE certification of the European Union, and has become the only Chinese anti epidemic product recommended by Dr. Stephen Hahn, director of FDA of the United States, on official twitter. At the same time, it has obtained the 5A supplier qualification of new crown testing reagent of the British government. With the development of the epidemic situation, the advantages of its highly specific molecular biological design have been fully reflected, and it has maintained the awareness of the emerging α, β, γ, δ There is no missed detection of virus variants, and it has maintained full excellence in the quality evaluation of authoritative regulatory agencies and official inspection centers in many countries and regions in the world, including FDA of the United States, China national clinical testing center, King's College Hospital NHS Foundation Trust of the United Kingdom, health protection center of the Hong Kong Department of health and so on. At present, COVID-19 nucleic acid reagents for marine organisms have been contributing to the fight against COVID-19 worldwide, and have been praised by overseas more than 30 English media and Spanish media.

Post time: Oct-13-2021